{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:56:08Z","timestamp":1785254168935,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-MS-360"],"award-info":[{"award-number":["2020-MS-360"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018559","name":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","doi-asserted-by":"publisher","award":["RC210267"],"award-info":[{"award-number":["RC210267"]}],"id":[{"id":"10.13039\/501100018559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00417-022-05948-4","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T09:03:51Z","timestamp":1671872631000},"page":"1571-1577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Spontaneous remission of vision degrading myodesopsia of posterior vitreous detachment type"],"prefix":"10.1007","volume":"261","author":[{"given":"Xing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Eric","family":"Pazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6000-8774","authenticated-orcid":false,"given":"Tiezhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"5948_CR1","first-page":"402","volume":"6","author":"BF Webb","year":"2013","unstructured":"Webb BF, Webb JR, Schroeder MC et al (2013) Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol 6:402\u2013405","journal-title":"Int J Ophthalmol"},{"key":"5948_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.survophthal.2015.11.008","volume":"61","author":"R Milston","year":"2016","unstructured":"Milston R, Madigan MC, Sebag J (2016) Vitreous floaters: etiology, diagnostics, and management. Surv Ophthalmol 61:211\u2013227","journal-title":"Surv Ophthalmol"},{"key":"5948_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/APO.0000000000000276","volume":"9","author":"GK Broadhead","year":"2020","unstructured":"Broadhead GK, Hong T, Chang AA (2020) To treat or not to treat: management options for symptomatic vitreous floaters. Asia Pac J Ophthalmol (Phila) 9:96\u2013103","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"5948_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamaophthalmol.2017.2388","volume":"135","author":"CP Shah","year":"2017","unstructured":"Shah CP, Heier JS (2017) YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial. JAMA Ophthalmol 135:918\u2013923","journal-title":"JAMA Ophthalmol"},{"key":"5948_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/1120672120968762","volume":"31","author":"GD Ludwig","year":"2021","unstructured":"Ludwig GD, Gemelli H, Nunes GM et al (2021) Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: a randomized controlled trial. Eur J Ophthalmol 31:909\u2013914","journal-title":"Eur J Ophthalmol"},{"key":"5948_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40123-021-00422-6","volume":"11","author":"T Lin","year":"2022","unstructured":"Lin T, Li T, Zhang X et al (2022) The efficacy and safety of YAG laser vitreolysis for symptomatic vitreous floaters of complete PVD or non-PVD. Ophthalmol Ther 11:201\u2013214","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"5948_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-019-0205-8","volume":"21","author":"CE Souza","year":"2020","unstructured":"Souza CE, Lima LH, Nascimento H et al (2020) Objective assessment of YAG laser vitreolysis in patients with symptomatic vitreous floaters. Int J Retina Vitreous 21(6):1","journal-title":"Int J Retina Vitreous"},{"key":"5948_CR8","first-page":"112067212110080","volume":"7","author":"BG Garc\u00eda","year":"2020","unstructured":"Garc\u00eda BG, Orduna Mag\u00e1n C, Alvarez-Peregrina C et al (2020) Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters. Eur J Ophthalmol 7:11206721211008036","journal-title":"Eur J Ophthalmol"},{"key":"5948_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/ICU.0000000000000752","volume":"32","author":"EH Ryan","year":"2021","unstructured":"Ryan EH (2021) Current treatment strategies for symptomatic vitreous opacities. Curr Opin Ophthalmol 32:198\u2013202","journal-title":"Curr Opin Ophthalmol"},{"key":"5948_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1755-3768.2009.01682.x","volume":"89","author":"S Schulz-Key","year":"2011","unstructured":"Schulz-Key S, Carlsson JO, Crafoord S (2011) Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. Acta Ophthalmol 89:159\u2013165","journal-title":"Acta Ophthalmol"},{"key":"5948_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/23258160-20180601-01","volume":"49","author":"CP Shah","year":"2018","unstructured":"Shah CP, Fine HF (2018) Management of floaters. Ophthalmic Surg Lasers Imaging Retina 49:388\u2013391","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5948_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/OPTH.S297307","volume":"15","author":"MD Wang","year":"2021","unstructured":"Wang MD, Truong C, Mammo Z et al (2021) Swept source optical coherence tomography compared to ultrasound and biomicroscopy for diagnosis of posterior vitreous detachment. Clin Ophthalmol 15:507\u2013512","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"5948_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/APO.0000000000000189","volume":"5","author":"MJ Tassignon","year":"2016","unstructured":"Tassignon MJ, N\u00ed Dhubhghaill S, Ruiz Hidalgo I et al (2016) Subjective grading of subclinical vitreous floaters. Asia Pac J Ophthalmol (Phila) 5(2):104\u2013109","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"5948_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/archopht.123.4.479","volume":"123","author":"KA van Overdam","year":"2005","unstructured":"van Overdam KA, Bettink-Remeijer MW, Klaver CC et al (2005) Symptoms and findings predictive for the development of new retinal breaks. Arch Ophthalmol 123(4):479\u2013484","journal-title":"Arch Ophthalmol"},{"key":"5948_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.eye.6700026","volume":"16","author":"YM Delaney","year":"2002","unstructured":"Delaney YM, Oyinloye A, Benjamin L (2002) Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye (Lond) 16:21\u201326","journal-title":"Eye (Lond)"},{"key":"5948_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ajo.2006.08.002","volume":"142","author":"JY Chuo","year":"2006","unstructured":"Chuo JY, Lee TY, Hollands H et al (2006) Risk factors for posterior vitreous detachment: a case-control study. Am J Ophthalmol 142:931\u2013937","journal-title":"Am J Ophthalmol"},{"key":"5948_CR17","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1172\/JCI111642","volume":"74","author":"TJ Smith","year":"1984","unstructured":"Smith TJ (1984) Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. Similar effects of glucocorticoid and thyroid hormones. J Clin Invest 74:2157\u20132163","journal-title":"J Clin Invest"},{"key":"5948_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI110694","volume":"70","author":"TJ Smith","year":"1982","unstructured":"Smith TJ, Murata Y, Horwitz AL et al (1982) Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro. J Clin Invest 70:1066\u20131073","journal-title":"J Clin Invest"},{"key":"5948_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/bjo.77.8.485","volume":"77","author":"WF Tsai","year":"1993","unstructured":"Tsai WF, Chen YC, Su CY (1993) Treatment of vitreous floaters with neodymium YAG laser. Br J Ophthalmol 77:485\u2013488","journal-title":"Br J Ophthalmol"},{"key":"5948_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.survophthal.2020.02.007","volume":"65","author":"D Su","year":"2020","unstructured":"Su D, Shah CP, Hsu J (2020) Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption. Surv Ophthalmol 65:589\u2013591","journal-title":"Surv Ophthalmol"},{"key":"5948_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12325-020-01261-w","volume":"37","author":"A Katsanos","year":"2020","unstructured":"Katsanos A, Tsaldari N, Gorgoli K et al (2020) Safety and efficacy of YAG laser vitreolysis for the treatment of vitreous floaters: an overview. Adv Ther 37:1319\u20131327","journal-title":"Adv Ther"},{"key":"5948_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.survophthal.2020.02.006","volume":"65","author":"IP Singh","year":"2020","unstructured":"Singh IP (2020) Modern vitreolysis-YAG laser treatment now a real solution for the treatment of symptomatic floaters. Surv Ophthalmol 65:581\u2013588","journal-title":"Surv Ophthalmol"},{"key":"5948_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/eye.2016.30","volume":"30","author":"T Ivanova","year":"2016","unstructured":"Ivanova T, Jalil A, Antoniou Y et al (2016) Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review. Eye (Lond) 30:645\u2013655","journal-title":"Eye (Lond)"},{"key":"5948_CR24","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.ophtha.2019.06.021","volume":"126","author":"JH Nguyen","year":"2019","unstructured":"Nguyen JH, Nguyen-Cuu J, Yu F et al (2019) Assessment of vitreous structure and visual function after neodymium:yttrium-aluminum-garnet laser vitreolysis. Ophthalmology 126:1517\u20131526","journal-title":"Ophthalmology"},{"key":"5948_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3928\/23258160-20200129-04","volume":"51","author":"CP Shah","year":"2020","unstructured":"Shah CP, Heier JS (2020) Long-term follow-up of efficacy and safety of YAG vitreolysis for symptomatic weiss ring floaters. Ophthalmic Surg Lasers Imaging Retina 51:85\u201388","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5948_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jamaophthalmol.2017.2477","volume":"135","author":"P Hahn","year":"2017","unstructured":"Hahn P, Schneider EW, Tabandeh H et al (2017) Reported complications following laser vitreolysis. JAMA Ophthalmol 135:973\u2013976","journal-title":"JAMA Ophthalmol"},{"key":"5948_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00417-012-2205-3","volume":"251","author":"KF de Nie","year":"2013","unstructured":"de Nie KF, Crama N, Tilanus MA et al (2013) Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction. Graefes Arch Clin Exp Ophthalmol 251:1373\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5948_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/IAE.0000000000000063","volume":"34","author":"JO Mason 3rd","year":"2014","unstructured":"Mason JO 3rd, Neimkin MG, Mason JO 4th et al (2014) Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters. Retina 34:1055\u20131061","journal-title":"Retina"},{"key":"5948_CR29","doi-asserted-by":"publisher","first-page":"5496298","DOI":"10.1155\/2017\/5496298","volume":"2017","author":"Z Lin","year":"2017","unstructured":"Lin Z, Zhang R, Liang QH et al (2017) Surgical outcomes of 27-gauge pars plana vitrectomy for symptomatic vitreous floaters. J Ophthalmol 2017:5496298","journal-title":"J Ophthalmol"},{"key":"5948_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ICU.0000000000000150","volume":"26","author":"DN Sommerville","year":"2015","unstructured":"Sommerville DN (2015) Vitrectomy for vitreous floaters: analysis of the benefits and risks. Curr Opin Ophthalmol 26:173\u2013176","journal-title":"Curr Opin Ophthalmol"},{"key":"5948_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40123-017-0111-9","volume":"6","author":"A Appeltans","year":"2017","unstructured":"Appeltans A, Mura M, Bamonte G (2017) Macular hole development after vitrectomy for floaters: a case report. Ophthalmol Ther 6:385\u2013389","journal-title":"Ophthalmol Ther"},{"key":"5948_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.oret.2020.07.015","volume":"5","author":"SM Rubino","year":"2021","unstructured":"Rubino SM, Parke DW 3rd, Lum F (2021) Return to the operating room after vitrectomy for vitreous opacities: intelligent research in sight registry analysis. Ophthalmol Retina 5:4\u20138","journal-title":"Ophthalmol Retina"},{"key":"5948_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1475-1313.1998.00387.x","volume":"18","author":"CN Serpetopoulos","year":"1998","unstructured":"Serpetopoulos CN, Korakitis RA (1998) An optical explanation of the entoptic phenomenon of \u2018clouds\u2019 in posterior vitreous detachment. Ophthalmic Physiol Opt 18:446\u2013451","journal-title":"Ophthalmic Physiol Opt"},{"key":"5948_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/08820538.2021.1887898","volume":"36","author":"M Kalavar","year":"2021","unstructured":"Kalavar M, Hubschman S, Hudson J et al (2021) Evaluation of available online information regarding treatment for vitreous floaters. Semin Ophthalmol 36:58\u201363","journal-title":"Semin Ophthalmol"},{"key":"5948_CR35","doi-asserted-by":"publisher","first-page":"100847","DOI":"10.1016\/j.preteyeres.2020.100847","volume":"79","author":"J Sebag","year":"2020","unstructured":"Sebag J (2020) Vitreous and vision degrading myodesopsia. Prog Retin Eye Res 79:100847","journal-title":"Prog Retin Eye Res"},{"key":"5948_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/aos.14012","volume":"97","author":"O Gishti","year":"2019","unstructured":"Gishti O, van den Nieuwenhof R, Verhoekx J et al (2019) Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: a systematic review. Acta Ophthalmol 97:347\u2013352","journal-title":"Acta Ophthalmol"},{"key":"5948_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archopht.119.10.1483","volume":"119","author":"KA van Overdam","year":"2001","unstructured":"van Overdam KA, Bettink-Remeijer MW, Mulder PG et al (2001) Symptoms predictive for the later development of retinal breaks. Arch Ophthalmol 119:1483\u20131486","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05948-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:04:30Z","timestamp":1684494270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05948-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5948"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05948-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research methods are in accordance with the tenets of the Declaration of Helsinki and approved by the ethics committee Board of the He Eye Specialist Hospital. Written informed consent was waived due to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors concur with the submission and agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}